Invetech
- Company typePrivate
- Founded1987
- HeadquartersMount Waverley, Australia
- Headcount251–500
- GTM typeB2B
- OfferingHardware or Manufacturing
Invetech firmographics
Firmographics- Name
- Invetech
- Legal name
- Invetech Pty. Ltd. and Invetech US LLC
- Website
- https://invetechgroup.com
- Company type
- Private
- Founded year
- 1987
- Operating status
- Operating
- Headcount range
- 251–500 employees
- Ownership category
- akta.pro rank
Invetech industry classification
Industry- Product category
- Medical Device Contract Manufacturing
- NAICS
- Analytical Laboratory Instrument Manufacturing (334516), Industrial Design Services (54142), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345)
- SIC
- Laboratory Analytical Instruments (3826), Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Process Development & Tech Transfer Services (CDMO) (HLAGABAL)
- akta.pro secondary industry
- Fill-Finish & Aseptic Drug Product Manufacturing (Biologics/ATMP) (HLAGAGAG)
Keywords
Where Invetech is headquartered
LocationHeadquarters
- HQ city
- Mount Waverley
- HQ country
- Australia
- HQ region
- Oceania
Offices2 records
Markets served
Invetech business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Infrastructure, Operations, Technology or R&D, Marketing or Sales, Supply Chain
Revenue model
- Contract Manufacturing Services: Manufacturing services for clinical diagnostics instruments, life science instruments, and cell & gene therapy automation platforms. Revenue generated through NPI (New Product Introduction) manufacturing, pilot builds, and commercial-scale production. Operates through ISO 9001, ISO 13485, FDA-registered, ISO Class 7, and GMP manufacturing capabilities.
- Product Development Services: Design and engineering services from concept through regulatory-ready production. Includes full-service partnership, strategic engineering support, and sustaining engineering services. Revenue generated through project-based engagements.
- Proprietary Platforms and Modules: Sale of proprietary configurable automation platforms including Korus counterflow centrifuge, Alta formulation and filling systems, Paddle Mixers, and Ensemble modular platforms for diagnostics and CGT applications.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Enterprise contract manufacturing - project-based pricing |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels6 records
Invetech product offering
Product offeringCore offering
Invetech designs, develops and manufactures proprietary automation platforms and provides full-service product development and contract manufacturing for in-vitro diagnostics (IVD) and cell & gene therapy (CGT) companies. The offering spans feasibility, design, engineering, regulatory-ready production and commercial-scale manufacturing, delivered alongside a portfolio of configurable products including the Korus counterflow centrifuge, Alta bag filling system, Paddle Mixer and Ensemble diagnostic platform.
Product overview
Invetech offers a platform-plus-modules architecture combining proprietary configurable automation products with comprehensive development and manufacturing services. The core product portfolio includes the Ensemble modular IVD development platform, Korus counterflow centrifuge system, Paddle Mixer for gentle cell mixing, Alta formulation and fill system, and Single-Use Consumables. These are complemented by service offerings in cell and gene therapy automation, IVD contract manufacturing, and product development services. The company operates manufacturing facilities in San Diego and Melbourne with ISO 13485, ISO 9001 certifications and FDA registration.
Differentiator
Problem solved
Functional benefit
Brands
- Korus™: Counterflow Centrifugation System for cell washing and elutriation in cell therapy manufacturing.
- Ensemble™
- Alta™
- Invetech Business Excellence (IBX)
Products and services
- Invetech Ensemble Modular diagnostic platform that accelerates product development by combining proven core technologies with customizable configurations for translating assays from lab to benchtop IVD and point-of-care instruments.
- Korus Counterflow Centrifuge System Automated counterflow centrifugation system for cell washing and elutriation in a closed, single-use system, producing cleaner starting material for downstream CGT processing with configurable protocols for different cell types and therapy workflows.
- Paddle Mixer Configurable, low-shear GMP-compatible paddle mixer for cell and gene therapy bioprocessing, designed for gentle mixing of living cells to preserve cell viability with consistent, repeatable agitation across single-use bags.
- Alta Formulation and Fill System Closed, automated bag filling system for aseptic fill and finish of advanced therapies that accurately dispenses therapeutic product into individual aliquot bags, replacing manual, variable, open processes with a GMP-ready fill operation.
- Single-Use Consumables Purpose-built bags, tubing, fluid path assemblies, and custom components engineered for CGT manufacturing, co-designed with Invetech's automation equipment to deliver closed, aseptic workflows.
- IVD Contract Manufacturing ISO-certified contract manufacturing services for clinical diagnostic and life science instruments, from pilot builds to commercial scale, including NPI manufacturing, design-to-manufacture transfer and ongoing production support.
- Cell & Gene Therapy Automation Solutions Custom automation, configurable platforms, and proprietary systems for autologous and allogeneic cell and gene therapies, including end-to-end automation, single-use consumables development, and GMP-aligned manufacturing solutions.
- Product Development Services Design and engineering services for diagnostics, medical devices and life sciences covering the full development journey from feasibility through regulatory-ready production, including feasibility, full-service partnership, strategic engineering support and sustaining engineering.
Quantifiable outcome
- Defect rate reduction from 50% to <1% for point-of-care device manufacturing over 5 years
- +3 more outcomes
Companies that use Invetech
Customer profileNamed customers12 records
Segments4 records
Ideal customer profiles3 records
Invetech technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature6 records
Invetech partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core.
- General FluidicscoreStrategic collaboration announced June 4, 2026, with Invetech serving as General Fluidics' development and scaleup partner for its Axess point-of-care diagnostic platform. Invetech was selected after a global search spanning four continents for its end-to-end manufacturing capability and diagnostics expertise. The partnership aims to accelerate bringing high-quality diagnostic testing from central labs directly to clinics, urgent care centers, and rural settings.
- Trenchant BioSystemscoreStrategic alliance to advance development and commercialization of Trenchant's fully automated AutoCell Platform for cell and gene therapy manufacturing. Testing data shows the platform could reduce CGT manufacturing costs by up to 80% and manufacturing time by up to 95%. The technology enables point-of-care production from a single unit of whole blood. Early access platform launch planned for early 2027, with full commercial release later that year.
- AiCellacoreStrategic collaboration to advance cell therapy innovation. Geoffrey Stephens, CEO of AiCella, stated: 'Their deep expertise in automation and instrument development creates a powerful foundation for advancing smarter, more scalable cell therapy manufacturing.'
Scale indicators9 records
Recent moves7 records
Expansion highlights5 records
Invetech competitors and assessment
Company assessmentBroad incumbents
- Catalent: Large-scale global CDMO offering development, manufacturing, and fill-finish services across biologics, cell therapy, and consumer health. Most relevant comparable for Invetech's contract manufacturing and CGT automation positioning, though materially larger and broader in scope.
- Lonza Group: World's largest CDMO with deep biologics, cell & gene therapy, and small-molecule manufacturing capabilities. Direct comparable on the CGT automation and bioprocess tooling side, particularly for Korus/Alta-style platforms.
- Sartorius AG: Leading bioprocessing supplier of upstream/downstream equipment, single-use consumables, and process automation. Comparable on the cell therapy bioprocess equipment, single-use consumables, and automation platform dimensions of Invetech's offering.
- Thermo Fisher Scientific (Patheon CDMO): Operates one of the largest CDMO networks (Patheon) plus extensive life-sciences instrumentation and CGT services through brands such as Cell Therapy Systems. Comparable across Invetech's CDMO and diagnostic instrumentation footprint.
Direct peers
- Miltenyi Biotec: Cell & gene therapy focused manufacturer of automation platforms (CliniMACS Prodigy), single-use disposables, and reagents for cell processing. Closest direct peer to Invetech on integrated CGT automation with consumables and instrument-software coupling.
- Hamilton Company: Privately held manufacturer of automated liquid handling workstations, lab automation, and process analytical instruments used in diagnostics and CGT workflows. Direct comparable on the precision-engineered, project-based IVD and life-sciences automation business.
- Tecan: Swiss manufacturer of laboratory automation, liquid handling, and IVD OEM components with strong project-based design and manufacturing services for diagnostic OEMs. Overlaps directly with Invetech's Ensemble modular diagnostic platform and IVD contract manufacturing offering.
- Beckman Coulter Life Sciences: Provider of laboratory automation, particle characterization, and bioprocess solutions for diagnostics, life-science research, and cell therapy. Comparable to Invetech's automation platform and consumables business serving diagnostics and CGT developers.
- West Pharmaceutical Services: Specialist in containment, delivery, and processing components for injectable drugs and advanced therapies, with growing CGT and fill-finish capabilities. Comparable to Invetech's Alta fill-finish system and consumables business for cell therapies.
Emerging players
- Cytiva (Danaher): Supplies bioprocessing equipment, single-use consumables, and cell therapy workflow solutions. Comparable to Korus/Alta/Paddle Mixer on CGT bioprocessing hardware, though Cytiva is rooted in larger commercial-scale biopharma rather than diagnostics OEMs.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
Invetech social profiles
Digital presenceInvetech compliance and trust
Trust signalCompliance3 records
Invetech financial estimates
Financial estimateRevenue estimate
Valuation estimate
Invetech leadership team
Management profileNumber of profiles
Profiles8 records
Invetech funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Invetech M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Invetech
What does Invetech do?
Invetech designs, develops and manufactures proprietary automation platforms and provides full-service product development and contract manufacturing for in-vitro diagnostics (IVD) and cell & gene therapy (CGT) companies. The offering spans feasibility, design, engineering, regulatory-ready production and commercial-scale manufacturing, delivered alongside a portfolio of configurable products including the Korus counterflow centrifuge, Alta bag filling system, Paddle Mixer and Ensemble diagnostic platform.
Is Invetech a public or private company?
Invetech is a private company. It is classified as management employee owned and is currently operating.
When was Invetech founded?
Invetech was founded in 1987. It employs 251 to 500 people.
Where is Invetech based?
Invetech is headquartered in Mount Waverley, Australia, in the Oceania region.
How does Invetech make money?
Three revenue lines are on record. Contract Manufacturing Services are the primary driver. The others are product Development Services and proprietary Platforms and Modules.
Who are Invetech's main competitors?
Broad incumbents on record are Catalent, Lonza Group, Sartorius AG and Thermo Fisher Scientific (Patheon CDMO). Direct peers are Miltenyi Biotec, Hamilton Company, Tecan, Beckman Coulter Life Sciences and West Pharmaceutical Services. Cytiva (Danaher) is listed as an emerging player.
Does Invetech have an API?
No public API is recorded for Invetech.
What industry is Invetech in?
Invetech's product category is Medical Device Contract Manufacturing. Its primary akta.pro industry code is HLAGABAL, Process Development & Tech Transfer Services (CDMO), with a secondary code of HLAGAGAG, Fill-Finish & Aseptic Drug Product Manufacturing (Biologics/ATMP). Its NAICS code is 334516 and its SIC code is 3826.